ITIF Search

Science and R&D

As nations engage in a race for global advantage in innovation, ITIF champions a new policy paradigm that ensures businesses and national economies can compete successfully by spurring public and private investment in foundational areas such as research, skills, and 21st century infrastructure. In the area of science and R&D policy, ITIF promotes public and private investment in research and development through public funding for research at national laboratories and universities, tax incentives to encourage business R&D, and policies to spur technology transfer from lab to market.


Why Congress Should Restore Full Expensing for Investments in Equipment and Research and Development

Why Congress Should Restore Full Expensing for Investments in Equipment and Research and Development

The tax law allowing firms to fully expense their research and development (R&D) costs expired at the end of 2021, and full expensing of equipment costs will begin phasing out in 2023. This decreases firms’ incentive to invest in these key drivers of economic growth and competitiveness. Congress should restore and make permanent full expensing for these investments.

More Publications and Events

July 8, 2024|Blogs

Fact of the Week: At Least 10 Percent of Scientific Research Is Being Co-Authored by AI

A recent working paper found that at least 10 percent of biomedical abstracts published in 2024 were found to have been written with a large language model.

June 10, 2024|Reports & Briefings

A Techno-Economic Agenda for the Next Administration

The next administration needs to place innovation, productivity, and competitiveness at the core of its economic policy. To that end, this report offers a comprehensive techno-economic agenda with 82 actionable policy recommendations.

May 15, 2024|Blogs

Assessing University-Industry Research Attention in Latin America and the Caribbean

The current scope of University-Industry (U-I) collaboration in Latin America and the Caribbean (LAC) opens opportunities for research to progress in innovative directions.

May 15, 2024|Blogs

The “Invent Here, Make Here” Act Should Fully Advance, Not Partially Impede, Bayh-Dole’s Mission

The bill proposes useful steps to facilitate domestic commercialization, but it overreaches in placing excessive restrictions when innovators prove unable to identify domestic manufacturing capabilities despite their best efforts.

May 13, 2024|Blogs

Advancing Biomedical Innovation With Policies Supporting Privacy-Enhancing Technologies

By improving privacy protection and facilitating secure collaborative research, privacy-enhancing technology could complement data-sharing policies and enable analysis of sensitive medical data and support biomedical innovation.

May 6, 2024|Reports & Briefings

The Relationship Between Biopharma R&D Investment and Expected Returns: Improving Evidence to Inform Policy

Better evidence is needed to evaluate the impact of policy changes on new drug development. Greater availability of government data should support more rigorous evaluations to inform evidence-based policymaking.

April 2, 2024|Testimonies & Filings

Comments to Canada’s Department of Finance Regarding Scientific Research and Experimental Development Tax Incentives

By changing the tax credit to be quasi-incremental, unifying the rates between small and large businesses, and simplifying the filing process, the government will be able to incentivize private R&D spending more effectively.

April 1, 2024|Blogs

How Political Transitions Affect Science, Technology, and Innovation Policies

A new research paper has found that calls for scientific research funding in Colombia increased over a 15-year period despite transitions in political control of the country’s government.

February 9, 2024|Blogs

A Closer Look at US Private Sector R&D Spending in a Global Context

Congress should pass the Tax Relief for American Families and Workers Act to restore full R&D expensing to drive U.S productivity, growth, and global competitiveness.

December 18, 2023|Blogs

Canada’s Innovation Gap: A Warning Sign for Economic Prosperity and National Security

Canada’s levels of business R&D are far off the pace in technologically advanced, globally traded sectors of the economy.

Back to Top